Heparin-induced thrombocytopenia
Information
- Disease name
- Heparin-induced thrombocytopenia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00043940 | Completed | Phase 3 | Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) | April 1999 | |
| NCT00198588 | Completed | Phase 3 | Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia | June 2005 | September 2006 |
| NCT00283322 | Completed | Heparin Antibodies in Intensive Care Unit Patients (HAICU) | November 2004 | May 2006 | |
| NCT00412464 | Completed | Phase 1 | Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis | September 2006 | December 2009 |
| NCT00456326 | Completed | Heparin-Induced Thrombocytopenia Registry | October 2005 | August 2007 | |
| NCT00489437 | Completed | Phase 1 | Heparin-Induced Thrombocytopenia Score Card Study | December 2007 | February 2013 |
| NCT00748839 | Completed | Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical | March 2009 | November 2012 | |
| NCT01654848 | Completed | Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients | January 2010 | August 2011 | |
| NCT02526485 | Completed | Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2 | March 2015 | September 5, 2018 | |
| NCT03979625 | Completed | Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation | January 1, 2016 | April 30, 2018 | |
| NCT05325346 | Completed | Phase 1 | A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects | March 7, 2022 | April 14, 2022 |
| NCT05586854 | Not yet recruiting | N/A | Multicenter Study on Dialysis Modalities for End-stage Chronic Renal Failure Patients With Heparin-induced Thrombocytopenia | November 20, 2022 | June 20, 2024 |
| NCT06066762 | Not yet recruiting | Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia. | November 1, 2023 | June 1, 2025 | |
| NCT05783895 | Recruiting | Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery | March 1, 2023 | June 1, 2023 | |
| NCT04842760 | Recruiting | PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer | June 1, 2021 | November 2023 | |
| NCT06033300 | Recruiting | N/A | Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia | April 17, 2023 | April 2026 |
| NCT00673439 | Terminated | Phase 2 | Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT) | November 2007 | September 2011 |
| NCT01598168 | Terminated | Phase 3 | Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia | January 2013 | July 2015 |
| NCT03809481 | Terminated | Phase 3 | Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban | May 16, 2019 | June 10, 2022 |
| NCT03594045 | Terminated | Phase 2 | Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT) | December 18, 2018 | October 30, 2019 |
| NCT00196417 | Unknown status | Phase 4 | The HIT-TRAP Trial | January 2003 | November 2005 |
| NCT00946400 | Unknown status | Validating 4Ts for Heparin Induced Thrombocytopenia (HIT) | August 2009 | ||
| NCT01102790 | Unknown status | Generation of Heparin-induced Thrombocytopenia (HIT)-Antibodies Without Prior Heparin Exposure | April 2010 | October 2010 | |
| NCT02717039 | Unknown status | Pharmacogenomics of Heparin-Induced Thrombocytopenia | March 2016 | December 2022 | |
| NCT03147638 | Unknown status | Phase 3 | Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT) | January 11, 2017 | June 30, 2019 |
| NCT03269019 | Unknown status | Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia | November 20, 2017 | December 31, 2019 | |
| NCT00198575 | Unknown status | A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients | November 2004 | March 2006 | |
| NCT04751357 | Unknown status | Argatroban Monitoring in Critically Ill Patients: Evaluation of a Novel Ecarin-based Bedside Test | August 1, 2020 | June 1, 2022 | |
| NCT04782843 | Unknown status | Evaluation of the Intra-observer Agreement of the HEP Score in Surgical Intensive Care. | March 1, 2021 | May 1, 2021 | |
| NCT00603824 | Withdrawn | Phase 4 | Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT) | January 2008 | July 2010 |
| NCT00759083 | Withdrawn | Phase 4 | Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients | September 2008 | May 10, 2010 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0011874
- OrphaNumber from OrphaNet (Orphanet)
- 3325